2019 MASCC/ISOO Meeting: Digital Health, Sexual Health, Treatment Toxicities, and Survivorship Print Email

2019 MASCC/ISOO Meeting Themes

Digital Health • Sexual Health • Treatment Toxicities • Cancer Survivorship

This year’s Annual Meeting will feature four themes of critical importance in supportive care: Digital health applications, sexual health, new toxicities arising from new treatments, and issues faced by cancer survivors. These themes are reflected in plenary sessions, parallel sessions, and workshops throughout the meeting.

DIGITAL HEALTH — Learn more about the intersection of technology and supportive care, from devices and AI to teleoncology. Several sessions will explore ways in which new information and communication technologies can be used to help meet the challenges of people with cancer. 

Plenary Session 1: Digital Health: Science Fact, Not Science Fiction – Friday, June 21
Chair: Ian Olver (Australia)
Roni Zeiger (USA): Digital Health and Oncology: Towards Connected Cancer Care 
Alice Landis-McGrath (USA): Overview of Artificial Intelligence (AI) 
David Rhew (USA): Overview of Virtual Reality, Augmented Reality, and Wearables  

Digital Health Parallel Session: Digital Health in Action – Friday, June 21
Chair: Declan Walsh (USA)
Ian Olver (Australia): Teleoncology
Christine Miaskowski (USA): Symptom Assessment of Cancer Patients 

SEXUAL HEALTH — A plenary session and three parallel sessions will be devoted to issues in sexual health in cancer patients: treatment strategies for sexual problems; body image, sexual dysfunction, and other problems among head and neck cancer patients; sexual health and dysfunction in adolescent and young adult cancer patients and survivors; and sexual issues in partners of cancer patients.

Plenary Session 3: Sexual Health: Treatment Strategies – Friday, June 21
Chair: Hope Rugo (USA)
John Mulhall (USA): Sexual Problems in Male Cancer Patients
Tami Rowen (USA): Sexual Problems in Female Cancer Patients
Francesca Duncan (USA): Oncofertility 

Parallel Session: Sexual Health in Head and Neck Cancer – Friday, June 21
Chairs: Deborah Saunders (Canada) and Cherry Estilo (USA)
Eleni Rettig (USA): Head and Neck Cancer and Sexuality in the Era of HPV: Common Patient Questions and Answers
Bethany Rhoten (USA): Body Image and Sexuality Research in Head and Neck Cancer
Kari Torbicki (Canada): Approaches to Interventions and Management Strategies for Sexual Dysfunction in Head and Neck Cancer
Nosayaba Osazuma-Peters (USA): Understanding Suicide Rate, Risk Factors, and Trends Among Head and Neck Cancer Survivors

Parallel Session: Let’s Talk About Sex – Friday, June 21
Chairs: Andrea Orsey (USA) and Jason Freedman (USA)
Natasha Frederick (USA): Sexual and Reproductive Health of Adolescent and Young Adult Patients
Faith Gibson (UK): Sexual Health and Preparedness in Survivors of Childhood Cancer: The Child-to-Adult Transition
Leslie Schover (USA): Sexual Dysfunction in Adolescent and Young Adult Patients and Survivors 

Parallel Session: Sexual Health: A Multidisciplinary Problem – Sunday, June 23
Chair: Penelope Schofield (Australia)
Debra Barton (USA): Sexual Problems in Cancer Patients: An Introduction
Shari Goldfarb (USA):  Overcoming the Barriers
Jane Ussher (Australia): Sexual Issues in Partners of Cancer Patients 

TREATMENT TOXICITIES — Advances in pharmacological and cellular treatments, as well as radiotherapy, have resulted in dramatic benefits for cancer patients, but also in new toxicities. A plenary session, a parallel session, and a workshop will be devoted to understanding the basic mechanisms and the variety of complications arising from new cancer treatments.

Plenary Session 2: New Treatments, New Toxicities (Saturday, June 22)
Chair: Rajesh Lalla (USA)
Ethan Basch (USA):  Patient-Reported Outcomes (PRO-CTCAE)
Crystal Mackall (USA): CAR T-Cell Therapy Toxicity
Sue Yom (USA): New Radiotherapy Modalities 

Parallel Session: Complications of Immunotherapy, I (Saturday, June 22)
Chairs: Bernardo Rapoport (South Africa) and Mario Lacouture (USA)
Bernardo Rapoport (South Africa):  Basic Mechanisms
Michael Postow (USA): Overview of Recommendations on Immune-Related Adverse Events
Tim Cooksley (UK): Emergencies
Anne Bass (USA): Rheumatological Toxicities
Jean Klastersky (Belgium): Renal Toxicities 

Workshop: Complications of Immunotherapy, II (Saturday, June 22)
Chairs: Bernardo Rapoport (South Africa) and Mario Lacouture (USA)
Michael Postow (USA): Pulmonary, Rare, and Multiple Toxicities
Mario Lacouture (USA): Skin Toxicities
Pamela Ginex (USA): Effective Patient-Healthcare Provider Communication
Michael Postow (USA): Case 1: Multiple Immune-Related Adverse Events
Michael Dougan (USA): Case 2: Colitis Refractory to Infliximab 

CANCER SURVIVORSHIP – Sessions will address cancer survivorship among children, adolescents, young adults, adults, and the elderly. A workshop will be offered on technological advances and emerging strategies for treatment-related symptoms. Topics include enhancement of self-management through the use of mobile health and innovative technologies to optimize symptom management and toxicity assessment. 

JASCC/MASCC Joint Session: Cancer Survivorship in Adolescents and Young Adults – Saturday, June 22
Chairs: Mitsue Saito (Japan) and Margaret Fitch (Canada)
Michael Feuerstein (USA): Overview of the Issues
Miyako Takahashi (Japan): Getting Back to "Normal”
Margaret Fitch (Canada): Follow-up of AYA Cancer Survivors
Alexandre Chan (Singapore): Ongoing Trials – AYA Cancer Survivors in Asia

Parallel Session: Cancer Survivorship Across the Life Cycle – Saturday, June 22
Chairs: Lidia Schapira (USA) and Bogda Koczwara (Australia)
Faith Gibson (UK): Pediatric and AYA Cancer Survivors
Michael Jefford (Australia): Adult Cancer Survivors
William Dale (USA): Geriatric Cancer Survivors 

Debate: Every Cancer Survivor Must Have a Written Survivorship Care Plan – Saturday, June 22
Facilitator: Lidia Schapira (USA)
Debaters: William Dale (USA), Faith Gibson (UK), Michael Jefford (Australia), Bogda Koczwara (Australia), Deborah Mayer (USA), and Enrique Soto-Perez de Celis (Mexico)

Workshop: Technological Advances and Emerging Strategies for Treatment-Related Symptoms During Cancer Survivorship – Sunday, June 23
Chair: Alexandre Chan (Singapore)
Doris Howell (Canada): Enhancing Self-Management Through the Use of Mobile Health
Maryam Lustberg (USA): Innovative Technologies to Optimize Symptom Management and Toxicity Assessment
Case Panel Discussion, Interactive Discussion, and a Strategic Plan Discussion on Future Research and Partnerships. Discussants: Karen Mustian (USA) and Raymond Chan (Australia)